AMETEK’s (AME) $5B Deal Bets Big On A Hot Streak

On August 26, AMETEK (NYSE: AME ) closed one of the largest deals in its history, an all-cash purchase of Indicor Instrumentation for $5.0 billion. The timing is notable. Three weeks earlier, on August 4, AMETEK had just posted record quarterly sales and raised its full-year guidance. Put the two together, and a pattern emerges: a company using a stretch of exceptional organic performance to fund an even bigger swing at growth.

AMETEK's second quarter told the story before the acquisition even closed. Sales hit a record $2.04 billion, up 15% from the same period in 2025, and adjusted earnings climbed 17% to $2.09 per diluted share. Operating margins expanded to 26.6%, a 60 basis point improvement, while operating cash flow jumped 35% to $483.7 million. Free cash flow conversion ran at 111% of net income, meaning AMETEK generated more cash than the accounting profit alone would suggest. Orders grew 28% in the quarter, the second straight quarter of what the company called exceptional demand, with the Electronic Instruments Group seeing particular strength in semiconductor and commercial aerospace markets and the Electromechanical Group benefiting from medtech, defense and automation orders.

The Indicor Instrumentation purchase builds directly on that momentum. The acquired businesses make mission-critical instrumentation for industrial and scientific customers, in end markets that align closely with AMETEK's existing portfolio, and generate recurring income from consumables, service work and aftermarket support long after the initial sale. Indicor Instrumentation is expected to add roughly $350 million to 2026 sales and be modestly accretive to adjusted earnings this year, and the businesses are being folded into AMETEK's existing Electronic Instruments and Electromechanical groups rather than run as a separate unit.

Not every number in the release flatters the story equally. AMETEK's GAAP earnings of $1.77 per diluted share ran well below the adjusted $2.09 figure, a 32-cent gap made up of non-cash charges tied to its acquisition history, plus one-time deal and integration expenses, a reminder that the growth machine carries real ongoing costs that adjusted figures tend to smooth over. The Indicor Instrumentation deal adds another $5.0 billion of cash spent in a single transaction, and AMETEK's own executives frame the payoff as coming from successfully integrating the acquired businesses into its operating model, which is another way of saying the value still depends on execution rather than being locked in at closing.